TREATING CANCER WITH A COMBINATION OF A PD-1 ANTAGONIST AND DINACICLIB
摘要
The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and the CDK inhibitor dincaciclib, and the use of the combination therapies for the treatment of cancer, and in particular for treating cancers that express PD-L1.
申请公布号
WO2015026634(A1)
申请公布日期
2015.02.26
申请号
WO2014US51171
申请日期
2014.08.15
申请人
MERCK SHARP & DOHME CORP.;STRACK, PETER RICHARD;BOOHER, ROBERT;SRIRAM, VENKATARAMAN;PHILLIPS, JOSEPH, H.
发明人
STRACK, PETER RICHARD;BOOHER, ROBERT;SRIRAM, VENKATARAMAN;PHILLIPS, JOSEPH, H.